The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Minimal residual illness, or MRD, testing might have the potential to supply peace of thoughts to survivors of breast most cancers, as a survivor and...
Dr. Vikram C. Gorantla, a medical oncologist at College of Pittsburgh Medical Middle, discusses key issues for sufferers with mind metastases resulting...
The U.S. Meals and Drug Administration (FDA) has granted accelerated approval to the CD20xCD3 bispecific antibody Lunsumio VELO (mosunetuzumab), as a subcutaneous...
Lynozyfic (linvoseltamab), a B-cell maturation antigen and CD3 bispecific antibody, confirmed a excessive total response fee and a tolerable security profile when...
